Last month, the US Patent and Trademark Office reignited the infamous CRISPR patent dispute when it declared interference—overlapping intellectual property—between several pending patents belonging to ...

CRISPR stocks are high risk but hold potential for aggressive investors. CRISPR Therapeutics and its partner Vertex Pharmaceuticals have the only approved CRISPR therapy. Several other biotech ...

She has a background in neuroscience ... Like the human immune system, bacteria learn from past infections. CRISPR sequences—short snippets of DNA from previous viruses—guide destructive enzymes ...